Indeed, complementing radiotherapy with anti-PD-L1 antibody treatment extended the efficacy of radiotherapy in mouse tumor models via cytotoxic T-cell activation, accompanied by reduced infiltration of immune suppressive myeloid cells (Deng et al. 2014a). Here, CD274 is linked to neoplasm.